TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16533338

Group type: EXPERIMENTAL
Intervention: Culture positive for Mycoplasma genitalium (group 1)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction-positive women (group 2)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Negative control women
Number of subjects: 390
Study: 12622238

Group type: COMPARATOR
Intervention: Food additive containing vitamin C, vitamin E, ubiquinone (Q10), vitamin A, and zinc oxide for four weeks
Number of subjects: 48
Study: 10228117

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP; 250 microgram twice a day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Salbutamol (Sb; 400 microgram twice a day)
Number of subjects: 30
Study: 8912948

Group type: EXPERIMENTAL
Intervention: Intravenous administration of meta-chlorophenylpiperazine (MCPP) at a dose of 0.06 mg/kg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 1864106

Group type: EXPERIMENTAL
Intervention: Leak of 2.0 mm internal diameter (ID) and 37 mm length (Ringqvist's leak)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Leak of 1.0 mm internal diameter (ID) and 15 mm length (Clausen's leak)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No leak
Number of subjects: 70
Study: 6419710

Group type: EXPERIMENTAL
Intervention: Low dose heparin
Number of subjects: 216

Group type: COMPARATOR
Intervention: Oxyphenbutazone/acetylsalicylic acid
Number of subjects: 216
Study: 30658658

Group type: EXPERIMENTAL
Intervention: Implementation strategies identified through an online survey and interviews at VAMCs.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Case reviews for patients identified by the STORM tool.
Number of subjects: 40
Study: 30547490

Group type: EXPERIMENTAL
Intervention: Physical activity counselling by GPs
Number of subjects: 3640

Group type: EXPERIMENTAL
Intervention: Interviews with GPs
Number of subjects: 3640

Group type: EXPERIMENTAL
Intervention: Implicit triage process by GPs
Number of subjects: 3640
Study: 24798350

Group type: EXPERIMENTAL
Intervention: Infliximab (3 mg/kg) combined with methotrexate (MTX) therapy, administered at weeks 0, 2, 6, and 14.
Number of subjects: 104

Group type: COMPARATOR
Intervention: MTX monotherapy (Control group).
Number of subjects: 104
Study: 23789705

Group type: EXPERIMENTAL
Intervention: T100 PARI (150 mg/1.5 mL) nebulized with a PARI eFlow nebulizer
Number of subjects: 78

Group type: COMPARATOR
Intervention: TOBI (300 mg/5 mL) nebulized with a PARI LC PLUS nebulizer
Number of subjects: 78
Study: 22412171

Group type: EXPERIMENTAL
Intervention: Excitatory theta burst stimulation (TBS) to the ipsilesional hemisphere
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inhibitory theta burst stimulation (TBS) to the contralesional hemisphere
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham TBS
Number of subjects: 41
Study: 18720474

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 41
Study: 16685253

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) 40 to 60 mg orally
Number of subjects: 12
Study: 15078394

Group type: EXPERIMENTAL
Intervention: Prophylactic advisory device replacement recommended for ICD implanted for secondary prevention
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prophylactic advisory device replacement recommended for pacemaker dependence
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prophylactic advisory device replacement recommended for prior appropriate ICD therapy
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prophylactic advisory device replacement recommended for higher likelihood of device malfunction
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prophylactic advisory device replacement recommended for physicians in practice <10 years
Number of subjects: 162
Study: 12452391

Group type: EXPERIMENTAL
Intervention: Loxiglumide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Balloon placement
Number of subjects: 12
Study: 10572343

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 7798068

Group type: EXPERIMENTAL
Intervention: Indapamide 1.25 mg once daily for 8 weeks
Number of subjects: 378

Group type: COMPARATOR
Intervention: Indapamide 2.5 mg once daily for 8 weeks
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Indapamide 1.25 mg
Number of subjects: 378

Group type: COMPARATOR
Intervention: Indapamide 2.5 mg
Number of subjects: 378
Study: 2750695

Group type: EXPERIMENTAL
Intervention: Tryptophan (3 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (3 g lactose)
Number of subjects: 8
Study: 776880

Group type: EXPERIMENTAL
Intervention: 5% methenamine in a firm stick gel, applied daily to one palmar or plantar surface
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 109
Study: 31233906

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over VMPFC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over rTPJ
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study: 28739344

Group type: EXPERIMENTAL
Intervention: cilostazol, probucol, or both
Number of subjects: 0
Study: 25501785

Group type: EXPERIMENTAL
Intervention: Aquacel Ag
Number of subjects: 29

Group type: COMPARATOR
Intervention: Xeroform
Number of subjects: 29
Study: 23657891

Group type: EXPERIMENTAL
Intervention: TIPS+E
Number of subjects: 106

Group type: COMPARATOR
Intervention: TIPS
Number of subjects: 106
Study: 22169724

Group type: EXPERIMENTAL
Intervention: Three stages of 5-aminolevulinic acid-photodynamic therapy (ALA-PDT)
Number of subjects: 56
Study: 19439137

Group type: EXPERIMENTAL
Intervention: Krakow end-to-end suturing technique (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Minimal invasive repair with Achillon suture system (Group 2)
Number of subjects: 40
Study: 17431366

Group type: EXPERIMENTAL
Intervention: Single oral dose of prulifloxacin (600 mg) before the operation
Number of subjects: 432

Group type: COMPARATOR
Intervention: 5-day course of prulifloxacin
Number of subjects: 432
Study: 15148065

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 11717015

Group type: EXPERIMENTAL
Intervention: Aprotinin (10(6) kallikrein inhibitory units (KIU) loading dose followed by the same dose during chest closure)
Number of subjects: 103
Study: 9219164

Group type: EXPERIMENTAL
Intervention: Fosinopril, 10 mg by mouth daily (treated group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 20
Study: 7632200

Group type: EXPERIMENTAL
Intervention: Child Behavior Checklist (CBCL) scores
Number of subjects: 890
Study: 2972054

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (240 micrograms, 40 micrograms each nostril, repeated twice at 15 min intervals)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 4599766

Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 41

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Phenylbutazone
Number of subjects: 41
Study: 31276460

Group type: EXPERIMENTAL
Intervention: Subtenon bupivacaine 0.5%
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 27206914

Group type: EXPERIMENTAL
Intervention: 35% phosphoric acid treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 25% PAA treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 17% EDTA treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 20
Study: 25231091

Group type: EXPERIMENTAL
Intervention: 300 mg peramivir
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 600 mg peramivir
Number of subjects: 12
Study: 23609340

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 302

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302
Study: 21467283

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625 mg/d
Number of subjects: 10739
Study: 18523440

Group type: EXPERIMENTAL
Intervention: 1.8 g/day plant sterols in margarine divided equally at each of the three daily meals (three times per day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1.8 g/day plant sterols in margarine with breakfast (single-BF)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control margarine with each meal
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Single-BF
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Three times per day
Number of subjects: 19
Study: 21656058

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Postpartum mothers
Number of subjects: 500
Study: 16005107

Group type: EXPERIMENTAL
Intervention: Individualized training and supervision by a clinical nurse specialist for catheter care in the intervention group (42 participants).
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard CVC procedures carried out by nurses in the control group (40 participants).
Number of subjects: 82
Study: 12430668

Group type: EXPERIMENTAL
Intervention: Plasma-reduced (PR) RBCs
Number of subjects: 597

Group type: COMPARATOR
Intervention: Buffy coat-depleted (BCD) RBCs
Number of subjects: 597

Group type: COMPARATOR
Intervention: WBC-filtered (WCF) RBCs
Number of subjects: 597
Study: 9799203

Group type: EXPERIMENTAL
Intervention: Oral methionine load (0.1 g/kg)
Number of subjects: 24
Study: 9345462

Group type: EXPERIMENTAL
Intervention: Recombinant interferon beta-1a (IFN-beta-1a) 6.0 x 10(6) IU (30 micrograms) administered by weekly intramuscular injections
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Recombinant interferon beta-1a (IFN-beta-1a)
Number of subjects: 301
Study: 2694049

Group type: EXPERIMENTAL
Intervention: Conjunctival autografting technique
Number of subjects: 35

Group type: COMPARATOR
Intervention: Bare sclera technique (Control)
Number of subjects: 35
Study: 742817

Group type: EXPERIMENTAL
Intervention: Treated hypertensive patients
Number of subjects: 34

Group type: COMPARATOR
Intervention: Untreated hypertensive patients
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both treated and untreated patients
Number of subjects: 34
Study: 11522101

Group type: EXPERIMENTAL
Intervention: ACE-I
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control
Number of subjects: 168
Study: 30872067

Group type: EXPERIMENTAL
Intervention: Care management intervention (add-on to existing disease management program)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Care management intervention (for female participants)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Standard care (for female participants)
Number of subjects: 495
Study: 29851157

Group type: EXPERIMENTAL
Intervention: Internet-based orthopaedic care platform
Number of subjects: 400

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 400
Study: 26011792

Group type: EXPERIMENTAL
Intervention: Outpatient uterine polypectomy
Number of subjects: 507

Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 507
Study: 24953046

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy with rosuvastatin
Number of subjects: 177

Group type: COMPARATOR
Intervention: Conventional therapy with pravastatin
Number of subjects: 177
Study: 21889304

Group type: EXPERIMENTAL
Intervention: Short Patient Information Leaflet (PIL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full Patient Information Leaflet (PIL)
Number of subjects: 0
Study: 20352147

Group type: EXPERIMENTAL
Intervention: Garlic supplementation
Number of subjects: 41
Study: 17510864

Group type: EXPERIMENTAL
Intervention: Conjunctival autograft (Group 1)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (Group 2)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Conjunctival autograft plus mitomycin C (Group 3)
Number of subjects: 49
Study: 15746633

Group type: EXPERIMENTAL
Intervention: Aspirin administration before surgery
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-aspirin (control) group
Number of subjects: 94
Study: 12153407

Group type: EXPERIMENTAL
Intervention: Application of cold using an ice-water pack
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of heat using a hot water bottle
Number of subjects: 0
Study: 9808219

Group type: EXPERIMENTAL
Intervention: 200 mg RRR-alpha-tocopheryl acetate
Number of subjects: 40
Study: 7649709

Group type: EXPERIMENTAL
Intervention: Cross Training (CT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Run Training (RT)
Number of subjects: 11
Study: 2663749

Group type: EXPERIMENTAL
Intervention: Timolol (without ISA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pindolol (with marked ISA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Timolol and Pindolol
Number of subjects: 20
Study: 1266422

Group type: EXPERIMENTAL
Intervention: D(‐)penicillamine (900 mg) plus salicylate (1500 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Prednisolone (10 mg) plus salicylate (1500 mg)
Number of subjects: 17
Study: 30598358

Group type: EXPERIMENTAL
Intervention: Healthy Conversation Skills (HCS)
Number of subjects: 70
Study: 28432468

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous acetaminophen administered over 15, 60, or 120 minutes
Number of subjects: 12
Study: 25545331

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (600 mg/d ubiquinol) with simvastatin 20 mg/d
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo with simvastatin 20 mg/d
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/d
Number of subjects: 120
Study: 23470188

Group type: COMPARATOR
Intervention: Gym membership
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Gym + PA education
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Gym + time during the workday
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Gym + education + time
Number of subjects: 410
Study: 22013704

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention conducted by schoolteachers who attended a nutritionist-led training course (group-1)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Nutrition education intervention conducted by schoolteachers who performed a self-training course (group-2)
Number of subjects: 813
Study: 18628521

Group type: EXPERIMENTAL
Intervention: Thyroid hormone administration (T(4) 50 microg and T(3) 0.67 microg/kg.d)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 8
Study: 16950363

Group type: EXPERIMENTAL
Intervention: Chaperonin 10 (5 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Chaperonin 10 (7.5 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Chaperonin 10 (10 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Chaperonin 10 (all doses)
Number of subjects: 23
Study: 12363191

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 254
Study: 10481501

Group type: EXPERIMENTAL
Intervention: Cleft group (patients with unilateral cleft lip and palate)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (patients without cleft)
Number of subjects: 90
Study: 8942005

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin injection using buffered regular insulin
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin injection using unbuffered regular insulin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Isophane insulin injected at bedtime
Number of subjects: 5
Study: 1723684

Group type: EXPERIMENTAL
Intervention: Urinary trypsin inhibitor for 3 days postoperatively
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no therapeutic agent)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Urinary trypsin inhibitor
Number of subjects: 22
Study: 7041937

Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg a day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bendrofluazide (5 mg a day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of indapamide and bendrofluazide
Number of subjects: 20
Study: 29462248

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy (PBC)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Non-platinum-based chemotherapy (NPBC)
Number of subjects: 215
Study: 28197774

Group type: EXPERIMENTAL
Intervention: Popliteal block + general anaesthesia (group P)
Number of subjects: 54

Group type: COMPARATOR
Intervention: General anaesthesia without popliteal block (group C)
Number of subjects: 54
Study: 26423425

Group type: EXPERIMENTAL
Intervention: Resistance training 2 days per week (G2X)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Resistance training 3 days per week (G3X)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Resistance training (both groups)
Number of subjects: 27
Study: 23640829

Group type: EXPERIMENTAL
Intervention: Foot Drop Stimulator (FDS)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Ankle Foot Orthosis (AFO)
Number of subjects: 197
Study: 21254041

Group type: EXPERIMENTAL
Intervention: Polypropylene (Prolene(®))
Number of subjects: 456

Group type: COMPARATOR
Intervention: Polydioxanone (PDS(®))
Number of subjects: 456
Study: 18258988

Group type: EXPERIMENTAL
Intervention: Locoregional therapy based on pretreatment clinical extent of disease and pathologic extent after chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant breast radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest-wall and regional nodal radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation
Number of subjects: 0
Study: 16474939

Group type: EXPERIMENTAL
Intervention: Low-intensity ultrasound (30 mW/cm2, 20 min/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 21
Study: 12924753

Group type: EXPERIMENTAL
Intervention: Desloratadine (5 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Promethazine (25 mg)
Number of subjects: 9
Study: 10994901

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 439

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 439
Study: 9481995

Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg/night)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (25 mg/night)
Number of subjects: 10
Study: 8180855

Group type: EXPERIMENTAL
Intervention: Mn-DPDP enhanced MRI
Number of subjects: 29

Group type: COMPARATOR
Intervention: DBCT
Number of subjects: 29
Study: 3371084

Group type: EXPERIMENTAL
Intervention: Frusemide/amiloride (40 mg frusemide plus 5 mg amiloride per tablet)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bumetanide/potassium chloride (0.5 mg bumetanide plus 573 mg slow‐release potassium chloride per tablet)
Number of subjects: 40
Study: 30201040

Group type: EXPERIMENTAL
Intervention: Baby Triple P Positive Parenting Programme plus treatment as usual (TAU)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 66
Study: 26816607

Group type: EXPERIMENTAL
Intervention: 40 mg/day duloxetine
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: 60 mg/day duloxetine
Number of subjects: 258
Study: 24576381

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (3 times a week for 8 weeks, 45-60 minutes at 60-70% heart rate reserve)
Number of subjects: 53
Study: 24331628

Group type: EXPERIMENTAL
Intervention: TACE combined with iodine [131I] metuximab injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: TACE therapy alone (Control Group)
Number of subjects: 60
Study: 20147334

Group type: EXPERIMENTAL
Intervention: GEM/capecitabine
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: GEM/cisplatin
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: GEM/5-fluorouracil
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: GEM/irinotecan
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: GEM/oxaliplatin
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (good PS)
Number of subjects: 4237

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (poor PS)
Number of subjects: 4237
Study: 18077217

Group type: EXPERIMENTAL
Intervention: Cetuximab plus gemcitabine and cisplatin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Gemcitabine and cisplatin
Number of subjects: 84
Study: 16632815

Group type: EXPERIMENTAL
Intervention: Oral granisetron (1 mg)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Intravenous ondansetron (4 mg)
Number of subjects: 220
Study: 12139908

Group type: EXPERIMENTAL
Intervention: St George Outreach Maternity Project (STOMP)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Unknown midwife during labour
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Postnatal care
Number of subjects: 1089
Study: 9793287

Group type: EXPERIMENTAL
Intervention: Fluconazole (50 mg daily for 14 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Itraconazole (100 mg daily for 15 days)
Number of subjects: 20
Study: 7759669

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 0
Study: 2518679

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (NGO, 18 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 22
Study: 333557

Group type: EXPERIMENTAL
Intervention: Pivampicillin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bacampicillin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6758932

Group type: EXPERIMENTAL
Intervention: 1 mg/kg tiapamil intravenously
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 30969142

Group type: EXPERIMENTAL
Intervention: Lower sodium chloride diet (6 g/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Higher sodium chloride diet (12 g/d)
Number of subjects: 15